Finke J H, Rayman P, Alexander J, Edinger M, Tubbs R R, Connelly R, Pontes E, Bukowski R
Section of Immunology, Cleveland Clinic Foundation, Ohio 44195.
Cancer Res. 1990 Apr 15;50(8):2363-70.
Previously we showed that IL2 expanded tumor-infiltrating lymphocytes (TILs) from renal cell carcinoma mediated non-major histocompatibility complex-restricted cytotoxicity. Phenotypic analysis showed that cultured TILs were composed mostly of T-lymphocytes with varying numbers of CD4+, CD8+, and CD56+ (Leu19+) populations. Here we compared the cytolytic activity of the two predominant TIL subsets, CD3+CD4+ and CD3+CD8+, to that of the CD56+ populations. Using magnetic beads coated with antibodies to either CD4 or CD8, CD3+CD4+, and CD3+CD8+ TILs were isolated in a highly enriched form (greater than 92%) and could be expanded for over 40 days in vitro with 1000 units/ml IL2. In a 4-h 51Cr release assay the CD4+ and CD8+ TILs showed minimal lytic activity, whereas unseparated cells exhibited significant levels of non-major histocompatibility complex-restricted cytotoxicity. The lytic activity seen in the 4-h assay with unseparated TILs appeared to be related to the presence of CD56+ populations. With one exception none of the purified CD4+ or CD8+ TILs expressed any significant levels of CD56, while the unseparated TILs contained varying numbers of CD3+CD56+ and CD3-CD56+ populations. Cell-sorting experiments verified that the CD56+ populations were responsible for most of the lytic activity in 4 h even though CD3+CD56- cells represented the predominant cell type. Although CD3+CD56- TILs were minimally lytic in 4 h, we show here that both CD3+CD4+ and CD3+CD8+ subsets displayed substantial cytotoxicity in long-term assays. In the 18-h 51Cr release assay 5 of 6 CD4+ and 2 of 3 CD8+ TILs were lytic for the autologous tumor. In two cases, restimulation with the autologous tumor induced augmented cytolytic activity of TIL subsets and in one case induced lytic activity in 4 h. The cytotoxic activity of TIL subsets was further examined using a 72-h assay in which TILs were cocultured with a confluent layer of tumor cells. The degree of cytotoxicity was quantitated by measuring the amount of crystal violet dye that was incorporated by tumor cells which remained after the incubation period. CD4+ and CD8+ TILs typically caused greater than a 50% reduction of tumor cells in 3 days and the level of reduction was increased when IL2 was added to the cultures. All the CD4+ and CD8+ subset preparations were cytotoxic in the 3-day assay even though some were not lytic for certain targets in the 18-h 51Cr release assay.(ABSTRACT TRUNCATED AT 400 WORDS)
此前我们发现,白细胞介素2(IL2)可扩增肾细胞癌的肿瘤浸润淋巴细胞(TILs),这些TILs介导非主要组织相容性复合体限制的细胞毒性。表型分析显示,培养的TILs主要由T淋巴细胞组成,包含数量不等的CD4 +、CD8 +和CD56 +(Leu19 +)细胞群。在此,我们比较了两个主要TIL亚群CD3 + CD4 +和CD3 + CD8 +与CD56 +细胞群的细胞溶解活性。使用包被有抗CD4或抗CD8抗体的磁珠,以高度富集的形式(大于92%)分离出CD3 + CD4 +和CD3 + CD8 + TILs,并且在含有1000单位/毫升IL2的培养基中可在体外扩增40多天。在4小时的51Cr释放试验中,CD4 +和CD8 + TILs显示出最小的溶解活性,而未分离的细胞表现出显著水平的非主要组织相容性复合体限制细胞毒性。在未分离的TILs进行的4小时试验中观察到的溶解活性似乎与CD56 +细胞群的存在有关。除一例例外,纯化的CD4 +或CD8 + TILs均未表达任何显著水平的CD56,而未分离的TILs含有数量不等的CD3 + CD56 +和CD3 - CD56 +细胞群。细胞分选实验证实,即使CD3 + CD56 -细胞是主要细胞类型,CD56 +细胞群在4小时内仍负责大部分溶解活性。尽管CD3 + CD56 - TILs在4小时内的溶解活性最小,但我们在此表明,在长期试验中,CD3 + CD4 +和CD3 + CD8 +亚群均表现出显著的细胞毒性。在18小时的51Cr释放试验中,6个CD4 + TILs中的5个和3个CD8 + TILs中的2个对自体肿瘤具有溶解作用。在两个病例中,用自体肿瘤再次刺激可增强TIL亚群的溶解活性,在一个病例中可在4小时内诱导出溶解活性。使用7小时试验进一步检测TIL亚群的细胞毒性活性,即将TILs与肿瘤细胞汇合层共培养。通过测量孵育期后残留肿瘤细胞摄取的结晶紫染料量来定量细胞毒性程度。CD4 +和CD8 + TILs通常在3天内使肿瘤细胞减少超过50%,当向培养物中添加IL2时,减少水平会增加。在3天试验中,所有CD4 +和CD8 +亚群制剂均具有细胞毒性,尽管在18小时的51Cr释放试验中,一些制剂对某些靶标没有溶解作用。(摘要截选至400字)